TY - BOOK PY - 2009 DA - 2009// TI - Abbott Laboratories, North Chicago, IL 60064 USA ID - ref1 ER - TY - JOUR AU - Klein, C. E. AU - Chiu, Y. I. AU - Awni, W. PY - 2007 DA - 2007// TI - The tablet formulation of lopinavir/ritonavir provides similar bioavailability to the soft-gelatin capsule formulation with less pharmacokinetic variability and diminished food effect JO - Journal of Acquired Immune Deficiency Syndromes VL - 44 UR - https://doi.org/10.1097/QAI.0b013e31803133c5 DO - 10.1097/QAI.0b013e31803133c5 ID - Klein2007 ER - TY - CHAP AU - Awni, W. AU - Chiu, Y. L. AU - Zhu, T. PY - 2005 DA - 2005// TI - Significantly reduced food effect and pharmacokinetic variability with a novel lopinavir/ritonavir tablet formulation BT - Abstract WeOa0206. 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment PB - Rio de Janeiro CY - Brazil ID - Awni2005 ER - TY - JOUR AU - Walmsley, S. AU - Bernstein, B. AU - King, M. PY - 2002 DA - 2002// TI - Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection JO - N Engl J Med VL - 346 UR - https://doi.org/10.1056/NEJMoa012354 DO - 10.1056/NEJMoa012354 ID - Walmsley2002 ER - TY - JOUR AU - Johnson, M. AU - Grinszstein, B. AU - Rodriguez, C. AU - Coco, J. AU - DeJesus, E. AU - Lazzarin, A. PY - 2005 DA - 2005// TI - Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures JO - AIDS VL - 19 UR - https://doi.org/10.1097/01.aids.0000166091.39317.99 DO - 10.1097/01.aids.0000166091.39317.99 ID - Johnson2005 ER - TY - BOOK PY - 2009 DA - 2009// TI - Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents ID - ref6 ER - TY - JOUR AU - Gathe, J. AU - Silva, B. A. AU - Cohen, D. E. PY - 2009 DA - 2009// TI - A Once-Daily Lopinavir/Ritonavir-Based Regimen Is Noninferior to Twice-Daily Dosing and Results in Similar Safety and Tolerability in Antiretroviral-Naive Subjects Through 48 Weeks JO - J Acquir Immune Defic Syndr VL - 50 UR - https://doi.org/10.1097/QAI.0b013e31819c2937 DO - 10.1097/QAI.0b013e31819c2937 ID - Gathe2009 ER - TY - JOUR AU - Sherman, D. S. AU - Fish, D. N. PY - 2000 DA - 2000// TI - Management of Protease Inhibitor-Associated Diarrhea JO - Clin Infect Dis VL - 30 UR - https://doi.org/10.1086/313826 DO - 10.1086/313826 ID - Sherman2000 ER - TY - JOUR AU - Bongiovanni, M. AU - Bini, T. AU - Chiesa, E. PY - 2004 DA - 2004// TI - Lopinavir/ritonavir vs. indinavir/ritonavir in antiretroviral naive HIV-infected patients: immunovirological outcome and side effects JO - Antiviral Res VL - 62 UR - https://doi.org/10.1016/j.antiviral.2003.12.002 DO - 10.1016/j.antiviral.2003.12.002 ID - Bongiovanni2004 ER - TY - JOUR AU - Schrader, S. AU - Chuck, S. K. AU - Rahn, L. W. PY - 2008 DA - 2008// TI - Significant improvements in self-reported gastrointestinal tolerability, quality of life, patient satisfaction, and adherence with lopinavir/ritonavir tablet formulation compared with soft gel capsules JO - AIDS Research and Therapy VL - 5 UR - https://doi.org/10.1186/1742-6405-5-21 DO - 10.1186/1742-6405-5-21 ID - Schrader2008 ER - TY - CHAP AU - Gathe, J. C. AU - Lipman, B. A. AU - Mayberry, C. PY - 2006 DA - 2006// TI - Tolerability and therapy preference of lopinavir/ritonavir (Kaletra®) soft-gel capsules and tablets as single agent in a cohort of HIV positive adult patients (IMANI-2) BT - Poster number P62. 8th International Congress on Drug Therapy in HIV Infection. Glasgow, UK ID - Gathe2006 ER - TY - CHAP AU - Rawlings, M. K. AU - McGhee, T. A. AU - Casey-Bailey, S. PY - 2007 DA - 2007// TI - Tolerability and preference of lopinavir/ritonavir (Kaletra) capsules versus tablets in an African American cohort BT - American Conference for the Treatment of HIV. Dallas, TX ID - Rawlings2007 ER - TY - CHAP AU - Shahriar, J. AU - Delate, T. AU - Hays, R. D. PY - 2003 DA - 2003// TI - Commentary on using the SF-36 or MOS-HIV in studies of persons with HIV disease BT - Health and Quality of Life Outcomes ID - Shahriar2003 ER - TY - JOUR AU - Sprinz, E. AU - Neto, J. A. AU - Bargman, E. PY - 2006 DA - 2006// TI - Substitution with lopinavir/ritonavir improves patient-reported outcomes including quality of life in patients who were intolerant to their antiretroviral therapy JO - HIV Clinical Trials VL - 7 UR - https://doi.org/10.1310/hct0706-291 DO - 10.1310/hct0706-291 ID - Sprinz2006 ER - TY - JOUR AU - Radloff, L. S. PY - 1977 DA - 1977// TI - The CES-D scale: a self-report depression scale for research in the general population JO - Applied Psychological Measurement VL - 1 UR - https://doi.org/10.1177/014662167700100306 DO - 10.1177/014662167700100306 ID - Radloff1977 ER -